Lifetime radiation-induced sarcoma risk in patients subjected to IMRT or VMAT for uterine cervix carcinoma
Authors:
- 28 April 2021
- journal article
- research article
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 44 (2) , 573-579
Abstract
This study was conducted to estimate the lifetime radiation-induced bone and soft tissue sarcoma risks from intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) for uterine cervix carcinoma. 13 cervical cancer patients were included. The bone and soft tissue structures were defined on patients’ treatment planning computed tomography (CT) scans. Both CT-based IMRT and VMAT plans with 6 MV photons delivering 45 Gy to the target site were designed for each patient. The organ equivalent dose (OED) and the lifetime attributable risk (LAR) for developing bone or soft tissue sarcoma were estimated using treatment planning data and a non-linear mechanistic model. The estimation method did not consider the survival rates following radiotherapy and the use of brachytherapy treatments. The patient-specific OEDs of the bone structure from IMRT and VMAT were 2.33–2.83 and 2.34–2.82 Gy, respectively. The corresponding values for the soft tissue structure were 1.27–1.70 and 1.32–1.73 Gy. An insignificant difference was found between the patient-specific OEDs and the directly proportional sarcoma risks (bone: P = 0.07; soft tissue: P = 0.38). The LAR for the development of a bone sarcoma varied from 0.05 to 0.16% by the patient’s age during irradiation and the applied treatment delivery technique. The corresponding LAR range for radiation-induced soft-tissue sarcoma was 0.08–0.27%. The above LARs resulted in a relative risk of more than 1.20 indicating that IMRT or VMAT may lead to a considerable risk increase of developing bone or soft tissue sarcoma exceeding 20% in respect to the current incidence of these malignancies in unexposed population.Keywords
Funding Information
- University of Crete (10599)
This publication has 22 references indexed in Scilit:
- Radiation dose and cancer risk to out‐of‐field and partially in‐field organs from radiotherapy for symptomatic vertebral hemangiomasMedical Physics, 2016
- The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumorsPhysics in Medicine & Biology, 2014
- Curative Radiation Therapy for Locally Advanced Cervical Cancer: Brachytherapy Is NOT OptionalInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Hematologic Toxicity in RTOG 0418: A Phase 2 Study of Postoperative IMRT for Gynecologic CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation fieldPhysics in Medicine & Biology, 2012
- Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapyTheoretical Biology and Medical Modelling, 2011
- Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy in Postoperative Treatment of Endometrial and Cervical CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Long-Term Survival and Risk of Second Cancers After Radiotherapy for Cervical CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term RiskJNCI: Journal of the National Cancer Institute, 2007
- Incidence of bone and soft tissue sarcoma after radiotherapy: A cohort study of 295,712 Finnish cancer patientsInternational Journal of Cancer, 2005